We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCLA:NASDAQPicoCELA Inc. Analysis

Data as of 2026-07-24 - not real-time

$5.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

PicoCELA Inc. (PCLA) is trading around $5.19, just above its 20‑day SMA (~$5.02) but below the 50‑day (~$5.18) and 200‑day (~$6.13) averages, signaling a bearish price trend. The RSI sits near 52, suggesting no immediate overbought/oversold condition, while the MACD line has crossed above its signal, offering a faint bullish hint that is outweighed by the overall “bearish” trend direction and a decreasing volume profile. Volatility is extreme at over 300% on a 30‑day basis and beta exceeds 1.6, indicating the stock moves sharply relative to the market.
Fundamentally, the company is under severe pressure: revenue fell 42% YoY, operating and net margins are deeply negative (over -100%), and both EBITDA and free cash flow are large negatives. Although cash on hand (~$535 M) exceeds debt (~$282 M), the cash burn remains high and the debt‑to‑equity ratio is near 60%, raising solvency concerns. Valuation metrics appear cheap – price‑to‑sales is under 0.1 and price‑to‑book is just above 2 – but these discounts reflect the deteriorating earnings and cash‑flow story rather than a genuine bargain. No dividend is paid, and the company’s ROE and ROA are strongly negative, underscoring the lack of sustainable profitability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below longer‑term moving averages
  • Decreasing volume and high short‑term volatility
  • Continued cash‑flow deficits

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent revenue decline and negative margins
  • Elevated debt burden relative to equity
  • Uncertain path to profitability

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if turnaround strategy succeeds
  • Low price‑to‑sales ratio may attract value seekers
  • High operational risk and need for structural improvements

Key Metrics & Analysis

Financial Health

Revenue Growth-42.30%
Profit Margin-114.98%
ROE-151.88%
ROA-32.38%
Debt/Equity59.91
P/B Ratio2.1
Op. Cash Flow$-544019968
Free Cash Flow$-412667616
Industry P/E15.3

Technical Analysis

TrendBearish
RSI51.8
Support$3.01
Resistance$11.56
MA 20$5.02
MA 50$5.18
MA 200$6.13
MACDBullish
VolumeDecreasing
Fear & Greed Index88.04

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.67
Volatility304.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.